We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Understand the cost of Promacta (eltrombopag) in India, factors influencing its price, and explore financial assistance options and generic alternatives.

Promacta, known generically as eltrombopag, is a vital medication used to treat specific blood disorders, particularly low platelet counts, in adults and some children. While its therapeutic benefits are significant, understanding the associated costs and exploring avenues for financial assistance is crucial for patients in India. This guide aims to provide a clear, practical overview of Promacta's pricing, factors influencing it, and potential support systems available.
Promacta (eltrombopag) is a prescription medication that works by stimulating the bone marrow to produce more platelets. It is primarily prescribed for conditions such as chronic immune thrombocytopenia (ITP), a disorder where the immune system destroys platelets, leading to a low platelet count and increased risk of bleeding. It may also be used in conjunction with other treatments for certain types of aplastic anemia and hepatitis C-related thrombocytopenia.
The price of Promacta in India can vary based on several factors:
As mentioned, generic drugs are designed to be bioequivalent to their brand-name counterparts. In India, the availability of generic eltrombopag offers a more affordable alternative for patients. While the brand name 'Promacta' might be more widely recognized, the generic version provides the same therapeutic benefits at a potentially reduced cost. Your doctor can guide you on switching to or starting with the generic option, and your insurance provider can clarify coverage details for both.
The pharmaceutical market in India is dynamic. Drug prices are influenced by manufacturing costs, research and development expenses (for innovator drugs), market demand, competition, and government regulations. For medications like Promacta, which may be used for chronic conditions, the long-term cost can be a significant consideration for patients and their families.
Several avenues can help mitigate the cost of Promacta for patients in India:
Many pharmaceutical companies that manufacture Promacta or its generic versions offer patient assistance programs. These programs may provide:
It is essential to check the official website of the drug manufacturer or inquire with your doctor or pharmacist about available programs. For instance, while the Novartis Patient Assistance Foundation is mentioned in international contexts, similar initiatives might exist or be adapted for the Indian market by local or multinational pharmaceutical companies operating in India.
If you have health insurance, understanding your policy is paramount. Key aspects to clarify include:
Contact your insurance provider directly or consult your HR department if your insurance is employer-provided.
India has various government health schemes aimed at providing affordable healthcare. While specific coverage for Promacta might vary, it's worth investigating if any national or state-level schemes, such as Pradhan Mantri Jan Arogya Yojana (PMJAY) or state-specific health insurance programs, offer benefits that could help offset the cost of such medications or related treatments.
Certain NGOs and charitable trusts focus on supporting patients with chronic illnesses. They might offer financial aid, medication support, or guidance on accessing healthcare resources. Researching organizations that support hematological disorders or specific patient groups could be beneficial.
Promacta belongs to a class of drugs called thrombopoietin receptor agonists. It's important to compare its cost not only with its generic version but also with other potential treatments for low platelet count. Some alternative treatments might be administered via injection, which could influence their overall cost and convenience compared to oral Promacta or eltrombopag. Your hematologist will be the best person to discuss the efficacy and cost-effectiveness of all available treatment options for your specific condition.
You should consult your doctor or healthcare provider if:
Disclaimer: This information is intended for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.

Montek LC tablet is applied in the treatment of allergies and asthma symptoms. This is an instructional manual on the usage, benefits, dosage and precautions to treat it safely and effectively.
April 11, 2026

Cyclopam tablet is commonly used for abdominal pain and cramps. This guide explains its uses, benefits, dosage, and safety precautions for effective relief.
April 11, 2026

Zincovit tablet is a multivitamin supplement that supports immunity and overall health. This guide explains its uses, benefits, dosage, and safety precautions for proper use.
April 11, 2026